Visit Us Monday- Thursday from 8.30 AM to 5.00 PM / Friday from 8.30 AM to 2.00 PM
78 Elma St W, Okotoks, AB
The mammalian target of rapamycin (mTOR) is a protein complex that regulates anabolic processes like protein synthesis, lipid production, and autophagy. Its activity depends on nutrient availability, especially amino acids, which are abundant in high-protein diets.
Research in animal models suggests that suppressing mTOR activity with interventions like rapamycin can extend lifespan. Chronic mTOR activation has been linked to hallmarks of aging, including:
Mitochondrial dysfunction
Loss of proteostasis
Cellular senescence
Stem cell exhaustion
Inhibition of mTOR with low-protein diets theoretically reduces these risks. However, this perspective oversimplifies the distinction between chronic mTOR activation and acute activation triggered by protein consumption.
High-protein diets stimulate mTORC1 activity in muscles, promoting muscle protein synthesis. This acute activation is beneficial for preserving muscle mass, especially as we age. Chronic mTOR activation, often suppressed by interventions like rapamycin, may have different effects in other tissues.
Insulin-like growth factor 1 (IGF-1) is another protein linked to longevity debates. Higher protein intake raises IGF-1 levels, which correlate with growth hormone activity.
Meta-analyses show that both low and high IGF-1 levels are associated with increased mortality, suggesting an optimal range for health. However:
Low IGF-1 Levels: Linked to reduced cancer risks but higher cardiovascular disease, frailty, and diabetes risks in humans.
High IGF-1 Levels: May accelerate tumor growth in certain contexts.
The relationship between dietary protein and IGF-1 is not straightforward. Studies show that IGF-1 naturally declines with age and becomes less influenced by protein intake after age 65. While protein consumption may acutely raise IGF-1 levels, long-term effects remain unclear.
Data on protein and aging in humans are limited and often conflicting.
NHANES III Analysis: Suggested that low protein intake may be beneficial for adults under 65, but higher protein intake is essential for older adults to reduce mortality risk.
Challenges in Interpretation: Results in younger adults may be skewed by underlying health conditions, while data in older adults more reliably show the importance of protein in mitigating frailty.
Protein restriction extends lifespan in mice, but these findings are difficult to apply to humans due to key differences:
Controlled Environments: Laboratory mice live in pathogen-free settings, while humans face immune challenges that require robust protein reserves.
Cause of Death: Mice primarily die from cancer, while humans are also at risk of accidents and frailty-related mortality.
Muscle Mass: In humans, maintaining muscle mass is critical for longevity, making higher protein intake advantageous.
Aging is associated with anabolic resistance, where the body becomes less efficient at using protein to maintain muscle. Increasing protein intake compensates for this resistance, reducing the risks of sarcopenia and frailty.
Protein malnutrition weakens immunity, increasing vulnerability to infections like pneumonia. Maintaining adequate protein intake supports the immune system, especially during acute illnesses.
Loss of muscle and bone density are key contributors to frailty in older adults. Adequate protein helps maintain strength and reduces fall-related injuries.
While concerns about mTOR activation and IGF-1 are valid in specific contexts, they are not sufficient to outweigh the benefits of protein for aging populations. Key takeaways include:
Moderate to High Protein Intake: Beneficial for older adults to maintain muscle mass, improve immune function, and reduce frailty.
Chronic vs. Acute mTOR Activation: Chronic suppression of mTOR (via rapamycin or other interventions) may complement acute mTOR activation from dietary protein.
Individualized Nutrition: Protein needs vary by age, health status, and activity levels.
At Foothills Wellness Clinic, we emphasize personalized nutrition strategies to support healthy aging. Whether you’re managing chronic conditions or looking to enhance longevity, our team helps tailor your diet to your unique needs.
"Healthy aging is not about adding years to life but life to years." – Unknown
Contact Us
📍 78 Elma St W, Okotoks, AB T1S 1J9
📞 403-938-3860
🌐 foothillswellnessclinic.ca
Original Article by: Samantha Lipman, Kathryn Birkenbach, Peter Attia
The mammalian target of rapamycin (mTOR) is a protein complex that regulates anabolic processes like protein synthesis, lipid production, and autophagy. Its activity depends on nutrient availability, especially amino acids, which are abundant in high-protein diets.
Research in animal models suggests that suppressing mTOR activity with interventions like rapamycin can extend lifespan. Chronic mTOR activation has been linked to hallmarks of aging, including:
Mitochondrial dysfunction
Loss of proteostasis
Cellular senescence
Stem cell exhaustion
Inhibition of mTOR with low-protein diets theoretically reduces these risks. However, this perspective oversimplifies the distinction between chronic mTOR activation and acute activation triggered by protein consumption.
High-protein diets stimulate mTORC1 activity in muscles, promoting muscle protein synthesis. This acute activation is beneficial for preserving muscle mass, especially as we age. Chronic mTOR activation, often suppressed by interventions like rapamycin, may have different effects in other tissues.
Insulin-like growth factor 1 (IGF-1) is another protein linked to longevity debates. Higher protein intake raises IGF-1 levels, which correlate with growth hormone activity.
Meta-analyses show that both low and high IGF-1 levels are associated with increased mortality, suggesting an optimal range for health. However:
Low IGF-1 Levels: Linked to reduced cancer risks but higher cardiovascular disease, frailty, and diabetes risks in humans.
High IGF-1 Levels: May accelerate tumor growth in certain contexts.
The relationship between dietary protein and IGF-1 is not straightforward. Studies show that IGF-1 naturally declines with age and becomes less influenced by protein intake after age 65. While protein consumption may acutely raise IGF-1 levels, long-term effects remain unclear.
Data on protein and aging in humans are limited and often conflicting.
NHANES III Analysis: Suggested that low protein intake may be beneficial for adults under 65, but higher protein intake is essential for older adults to reduce mortality risk.
Challenges in Interpretation: Results in younger adults may be skewed by underlying health conditions, while data in older adults more reliably show the importance of protein in mitigating frailty.
Protein restriction extends lifespan in mice, but these findings are difficult to apply to humans due to key differences:
Controlled Environments: Laboratory mice live in pathogen-free settings, while humans face immune challenges that require robust protein reserves.
Cause of Death: Mice primarily die from cancer, while humans are also at risk of accidents and frailty-related mortality.
Muscle Mass: In humans, maintaining muscle mass is critical for longevity, making higher protein intake advantageous.
Aging is associated with anabolic resistance, where the body becomes less efficient at using protein to maintain muscle. Increasing protein intake compensates for this resistance, reducing the risks of sarcopenia and frailty.
Protein malnutrition weakens immunity, increasing vulnerability to infections like pneumonia. Maintaining adequate protein intake supports the immune system, especially during acute illnesses.
Loss of muscle and bone density are key contributors to frailty in older adults. Adequate protein helps maintain strength and reduces fall-related injuries.
While concerns about mTOR activation and IGF-1 are valid in specific contexts, they are not sufficient to outweigh the benefits of protein for aging populations. Key takeaways include:
Moderate to High Protein Intake: Beneficial for older adults to maintain muscle mass, improve immune function, and reduce frailty.
Chronic vs. Acute mTOR Activation: Chronic suppression of mTOR (via rapamycin or other interventions) may complement acute mTOR activation from dietary protein.
Individualized Nutrition: Protein needs vary by age, health status, and activity levels.
At Foothills Wellness Clinic, we emphasize personalized nutrition strategies to support healthy aging. Whether you’re managing chronic conditions or looking to enhance longevity, our team helps tailor your diet to your unique needs.
"Healthy aging is not about adding years to life but life to years." – Unknown
Contact Us
📍 78 Elma St W, Okotoks, AB T1S 1J9
📞 403-938-3860
🌐 foothillswellnessclinic.ca
Original Article by: Samantha Lipman, Kathryn Birkenbach, Peter Attia
OUR HEAD CLINIC
78 Elma St W, Okotoks, AB T1S 1J9
We Work for You Mon-Thu
from 8.30 AM to 5.00 PM
Fri - 8.30 AM to 12.30 PM
© 2025 Foothills Wellness Clinic. All Rights Reserved.